Anupama Nehra, M.D. – FDA Inspection, Mar 24, 2025

Record Details

This FDA Inspection record concerns Anupama Nehra, M.D., with an inspection on March 24, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Anupama Nehra, M.D.
Inspection Date: March 24, 2025
Product Type: Human Drugs
Office: New Jersey District Office
Person: Tyanna N. Hadley (Company Rep)

View Company Profile

ID · 6c7df3b2-ae98-4d9b-94e7-c02769e35af3

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1264670
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate
21 CFR 312.62(c)Record retention

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Anupama Nehra, M.D.

FDA Inspection

Anupama Nehra, M.D.March 24, 2025